Anti-hepatitis B virus in clinical research medicine.docVIP

 PAGE \* MERGEFORMAT 8 Anti-hepatitis B virus in clinical research medicine [Abstract] [Objective] Treatment of Fuzheng anti-drug and inactive HBV carriers clinical antiviral efficacy. [Method] The three lines of hepatitis B, “three positive”, HBV DNA positive, normal liver function inactive 77 cases of hepatitis B virus carriers, the overall self-control law, anti-drug Treatment of righting observed changes in HBV DNA titer. [Results] 77 patients with HBV DNA negative in 58 cases, the recent negative rate of 75% Of the 58 cases negative HBV DNA rebound in 8 cases, 14%, 7 cases of relapse, accounting for 12%. [Conclusion] Fuzheng anti-drug side of the inactive HBV carriers have a good short-term effect; can inhibit or clear the hepatitis B virus. [Keywords:] Hepatitis B virus carrier; inactive; Chinese medicine; Anti-Virus In order to explore the Chinese method of the possibility of anti-hepatitis B virus, the effectiveness of the author from January 2006 to January 2009, selected three lines of hepatitis B, “Small three” (HBsAg, anti-a HBe, anti-HBc positive one), HBV DNA-positive, non-normal liver function active hepatitis B virus (HBV) carriers, 77 cases, according to Chinese medicine theory and the overall concept of the idea of treating disease, since the overall control law to be, righting anti-drug, and achieved satisfactory effect . 1 Materials and Methods 1.1 Clinical data selected three lines of hepatitis B, “three positive”, HBV DNA positive, normal liver function, more systematic clinical observation of 77 cases, are in-patients. 53 cases were male, 24 female, aged 13 years minimum, maximum 62 years old, 20 to 40 people between the ages of 59 and 40 years of age, 50 years of age 12. HBV DNA titer of 103 copies / ml, 10, 104 copies / ml, 33, 105 copies / ml of 22, 106 copies / ml, 8, 107 copies / ml copies 4. diagnose disease 2 to 20 years, mostly in the 2 to 6 years. 1.2 The test method test newly diagnosed patients with thr